Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics on track to report data from KALM-2 Phase 3 trial in 2Q20 CARA
11:25am, Wednesday, 25'th Mar 2020
Cara Therapeutics on track to report data from KALM-2 Phase 3 trial in 2Q20 CARA
Cara Therapeutics Reports Clinical Updates
11:00am, Wednesday, 25'th Mar 2020
- On track to report topline data for KALM-2 Phase 3 global trial of KORSUVA™ Injection in second quarter – - On track to complete interim statistical.
Edited Transcript of CARA earnings conference call or presentation 27-Feb-20 9:30pm GMT
10:49am, Monday, 23'rd Mar 2020
Q4 2019 Cara Therapeutics Inc Earnings Call
Imagine Owning Cara Therapeutics (NASDAQ:CARA) And Wondering If The 43% Share Price Slide Is Justified
12:51pm, Saturday, 21'st Mar 2020
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...
Edited Transcript of CARA earnings conference call or presentation 27-Feb-20 9:30pm GMT
04:44pm, Friday, 20'th Mar 2020
Q4 2019 Cara Therapeutics Inc Earnings Call
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs March 19.) * Biomerica, Inc. (NASDAQ: BMRA) * Centogene NV (
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 19.)
Biomerica, Inc. (NASDAQ...
Cara Therapeutics Inc (NASDAQ:CARA) Receives Consensus Rating of "Buy" from Brokerages
07:22am, Thursday, 19'th Mar 2020
Cara Therapeutics Inc (NASDAQ:CARA) has received a consensus rating of “Buy” from the eight brokerages that are covering the company, Marketbeat Ratings reports. Two investment analysts have rated
The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection
12:00am, Thursday, 19'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 18)
Biomerica, Inc. (NASDAQ...
Franklin Resources Inc. Has $9.07 Million Stake in Cara Therapeutics Inc (NASDAQ:CARA)
09:50am, Tuesday, 17'th Mar 2020
Franklin Resources Inc. trimmed its position in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 2.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange
Charles Schwab Investment Management Inc. Increases Holdings in Cara Therapeutics Inc (NASDAQ:CARA)
10:08am, Sunday, 15'th Mar 2020
Charles Schwab Investment Management Inc. grew its holdings in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 2.3% in the 4th quarter, according to the company in its most recent filing with the Sec
Cara Therapeutics (NASDAQ:CARA) Hits New 12-Month Low at $11.29
09:20am, Saturday, 14'th Mar 2020
Cara Therapeutics Inc (NASDAQ:CARA)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $11.29 and last traded at $11.60, with a volume of 9561 shar
Cara Therapeutics Inc (NASDAQ:CARA) Expected to Post Earnings of -$0.64 Per Share
08:30am, Friday, 13'th Mar 2020
Analysts expect Cara Therapeutics Inc (NASDAQ:CARA) to announce earnings of ($0.64) per share for the current fiscal quarter, according to Zacks. Five analysts have issued estimates for Cara Therapeut
Cara Therapeutics (NASDAQ:CARA) Lowered to "Hold" at BidaskClub
06:32am, Friday, 13'th Mar 2020
Cara Therapeutics (NASDAQ:CARA) was downgraded by analysts at BidaskClub from a “buy” rating to a “hold” rating in a research note issued to investors on Friday, BidAskClub reports. Several ot
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
